Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

American Journal of Kidney Diseases

Volumn 41, Issue 2, 2003, Pages 319-327

  Morales, Enrique ^a   Valero, Ma Angeles ^a   León, Miguel ^a   Hernández, Eduardo ^a   Praga, Manuel ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Low calorie diet; Overweight; Proteinuria decrease; Type 2 diabetes; Weight loss

Indexed keywords

CREATININE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; FEMALE; HUMAN; KIDNEY DISEASE; LOW CALORY DIET; MALE; OBESITY; PROTEINURIA; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0037309569     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50039     Document Type: Article

References (33)

1. Jennette JC, Charles L, Grubb W: Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis 10:470-472, 1987
2. Verani RR: Obesity-associated focal segmental glomerulosclerosis: Pathological features of the lesions and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 20:629-634, 1992
3. Kambham N, Markowitz G, Valeri AM, et al: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59:1498-1509, 2001
4. Praga M, Hernández E, Herrero JC, et al: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58:2111-2118, 2000
5. Praga M, Hernández E, Morales E, et al: Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 16: 1790-1798, 2001
6. Praga M, Hernández E, Andres A, et al: Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 70:35-41, 1995
7. Harris JA, Benedict FG: Biometric Studies of Basal Metabolism in Man. Washington, DC, Carnegie Institution of Washington, 1919 (publication no. 279)
8. Tighe AP, Allison DB, Kral JG, Heymsfiel SB: Nutrition support of obese patients, in Rombeau JL, Caldwell MD (eds): Clinical Nutrition: Parenteral Nutrition (ed 2). Philadelphia, PA, Saunders, 1993, pp 649-666
9. Cockcroft DW. Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
10. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339:1448-1456, 1998
11. Hebert L, Agarwal G, Sedmak DD, et al: Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney Int 57:1962-1967, 2000
12. Klahr S, Levey AS, Beck GJ, et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
13. Hunsicker L, Adler S, Caggiula A, et al: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51:1908-1919, 1997
14. Maschio G, Alberti D, Janin G, et al: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
15. The GISEN Group: Randomised placebo-controlled trial of effect of ramipril on declining glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857-1863, 1997
16. Ruggenenti P, Perna A, Gherardi G, et al: Renoprotective properties of ACE inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354:359-364, 1999
17. Lewis EJ, Hunsicker L, Bain RP, Rhode RP, for the Collaborative Study Group: The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
18. Praga M, Hernández E, Montoyo C, et al: Long-term beneficial effects of ACE inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20:240-248, 1992
19. Gansevoort RT, Sluiter WJ, Hemmelder MH, et al: Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials. Nephrol Dial Transplant 10:1963-1974, 1995
20. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Guideline 4: Estimation of GFR. Am J Kidney Dis 39:S76-S92, 2002 (suppl 1)
21. Ritz E, Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127-1133, 1999
22. Lewis EJ, Hunsicker LG, Clarke WR, et al for the Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
23. Brenner BM, Cooper ME, De Zeeuw D, et al for the RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
24. Hostetter TH: Prevention of end-stage renal disease due to type 2 diabetes. N Engl J Med 345:910-912, 2001
25. Oda H, Keane W: Recent advances in statins and the kidney. Kidney Int Suppl 71:S2-S5, 1999
26. Fried LF, Orchard TJ, Kasiske BL for the Lipids and Renal Disease Progression Meta-Analysis Study Group: Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 59:260-269, 2001
27. Hebert LA, Wilmer WA, Falkenhain ME, et al: Reno-protection: One or many therapies? Kidney Int 59:1211-1226, 2001
28. Hall JE, Brandy MW, Henegar JR, Shek EW: Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol 25:58-64, 1998
29. Chagnac A, Weinstein T, Korzets A, et al: Glomerular hemodynamics in severe obesity. Am J Physiol 278:F817-F822, 2000
30. Dengel DR, Glodberg AP, Mayuga RS, et al: Insulin resistance, elevated glomerular filtration reaction and renal injury. Hypertension 28:127-132, 1996
31. Tucker BJ, Anderson CM, Thies RC, et al: Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int 42:1160-1168, 1992
32. Kasiske BL, O'Donnell MP, Keane WF: The Zucker rat model of obesity, insulin resistance, hyperlipidemia and renal injury. Hypertension 19:SI110-SI115, 1992 (suppl 1)
33. Wolf G, Hamman A, Han DC, et al: Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells. Potential role in glomerulosclerosis. Kidney Int 56:860-872, 1999